Skip to main content

 9Z7M | pdb_00009z7m

Human CD38 bound to ligand-ADPR adduct


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.84 Å
  • R-Value Free: 
    0.225 (Depositor), 0.224 (DCC) 
  • R-Value Work: 
    0.186 (Depositor), 0.187 (DCC) 
  • R-Value Observed: 
    0.188 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9Z7M

This is version 1.0 of the entry. See complete history. 

Literature

Discovery of Potent and Orally Bioavailable Novel Cluster of Differentiation 38 (CD38) Small Molecule Inhibitors.

Shiroodi, R., Montavon, T.J., Nelson, B.M., Randolph, J.T., O'Flynn, D.E., Iu, L., Hutchins, C.W., Baikstis, T., Izquierdo-Ferrer, J., Smyth, D., Krishnan, N., Maneshi, M.M., Brown, J.W., Afanador, G.A., Jain, R., Karunan Partha, S., Bigelow, L., Nocek, B., Talaga, L., Gopalakrishnan, S.M., Balakrishnan, A., Sheehan, M.M., Kurschner, V.A., Jejurkar, P.C., Nacham, O., Hu, D., Yarilina, A., Bradley, N.P., Chapman, A.M., Thakur, A., Panchal, S.C., Sunose, M., Zoi, I., Dart, M.J., Shotwell, J.B., Benekareddy, M., Sadowski, R.N., Swensen, A.M.

(2026) J Med Chem 69: 13188-13206

  • DOI: https://doi.org/10.1021/acs.jmedchem.6c00171
  • Primary Citation Related Structures: 
    9Z7M

  • PubMed Abstract: 

    Herein, we report the discovery and optimization of a series of cluster of differentiation 38 (CD38) inhibitors derived from a virtual ligand screening (VLS) campaign. VLS identified imidazopyridazine hit 9 , which was optimized to a novel and potent CD38 inhibitor peripheral tool 25 ( A-8531 ) with an excellent pharmacokinetic profile. A cocrystal structure in addition to biophysical and biochemical characterization of 25 is consistent with uncompetitive inhibition of CD38 via the formation of covalent adduct 28 . Further structure- and property-based modifications of 25 afforded sulfuryl pyrazole 39 ( A-3190 ) with improved CNS distribution properties. Brain-penetrant thienopyrimidine 39 shows robust rodent pharmacokinetics and in vivo target engagement across skin, lung, liver, and brain, making it an excellent CD38 tool for the study of indications requiring engagement of CD38 in the brain.


  • Organizational Affiliation: 
    • AbbVie Inc., North Chicago, Illinois 60064, United States.

Macromolecule Content 

  • Total Structure Weight: 31.79 kDa 
  • Atom Count: 2,310 
  • Modeled Residue Count: 259 
  • Deposited Residue Count: 262 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1262Homo sapiensMutation(s): 0 
Gene Names: CD38
EC: 3.2.2 (PDB Primary Data), 3.2.2.6 (PDB Primary Data), 2.4.99.20 (PDB Primary Data)
UniProt & NIH Common Fund Data Resources
Find proteins for P28907 (Homo sapiens)
Explore P28907 
Go to UniProtKB:  P28907
PHAROS:  P28907
GTEx:  ENSG00000004468 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP28907
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
A1C07
(Subject of Investigation/LOI)

Query on A1C07



Download:Ideal Coordinates CCD File
B [auth A][[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{S},4~{R},5~{R})-5-[4-[2-azanyl-6-[4-[cyclopropyl(methyl)carbamoyl]phenyl]imidazo[1,2-b]pyridazin-3-yl]pyridin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl hydrogen phosphate
C37 H42 N11 O14 P2
QCCQFMJAVZRMHV-PEJGCKAISA-O
SO4

Query on SO4



Download:Ideal Coordinates CCD File
C [auth A],
D [auth A],
E [auth A],
F [auth A]
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
CL

Query on CL



Download:Ideal Coordinates CCD File
G [auth A],
H [auth A]
CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.84 Å
  • R-Value Free:  0.225 (Depositor), 0.224 (DCC) 
  • R-Value Work:  0.186 (Depositor), 0.187 (DCC) 
  • R-Value Observed: 0.188 (Depositor) 
Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 96.03α = 90
b = 68.14β = 92.829
c = 53.91γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
autoPROCdata reduction
XSCALEdata scaling
PHENIXphasing

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Other private--

Revision History  (Full details and data files)

  • Version 1.0: 2026-11-18
    Type: Initial release